These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28235487)

  • 1. CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.
    Taniguchi H; Ito S; Ueda T; Morioka Y; Kayukawa N; Ueno A; Nakagawa H; Fujihara A; Ushijima S; Kanazawa M; Hongo F; Ukimura O
    Biochem Biophys Res Commun; 2017 Apr; 485(2):267-271. PubMed ID: 28235487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
    Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
    Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma.
    Wang J; Yang WJ; Sun C; Luan Y; Cheng GH; Li KL; Kong F
    Oncol Res; 2014; 22(4):219-224. PubMed ID: 26351211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.
    Zhang Y; Yuan Y; Liang P; Guo X; Ying Y; Shu XS; Gao M; Cheng Y
    Oncotarget; 2017 May; 8(18):30008-30018. PubMed ID: 28404905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
    Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma.
    Bousquet G; El Bouchtaoui M; Leboeuf C; Battistella M; Varna M; Ferreira I; Plassa LF; Hamdan D; Bertheau P; Feugeas JP; Damotte D; Janin A
    Oncotarget; 2015 Aug; 6(22):19279-89. PubMed ID: 26002555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21‑cyclin E2‑Bax/caspase-3 signaling pathway.
    Liu Z; Lu Y; Xiao Y; Lu Y
    Oncol Rep; 2017 Mar; 37(3):1437-1444. PubMed ID: 28184919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
    Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
    Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Prognostic Significance of
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwińska-Jewsiewicka A; Wierzbicki PW; Kmieć Z
    Anticancer Res; 2017 Jun; 37(6):2927-2937. PubMed ID: 28551630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism.
    Gurova KV; Hill JE; Razorenova OV; Chumakov PM; Gudkov AV
    Cancer Res; 2004 Mar; 64(6):1951-8. PubMed ID: 15026329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
    Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T
    Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells.
    Patergnani S; Guzzo S; Mangolini A; dell'Atti L; Pinton P; Aguiari G
    Exp Cell Res; 2020 Oct; 395(1):112190. PubMed ID: 32717219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
    Macher-Goeppinger S; Keith M; Tagscherer KE; Singer S; Winkler J; Hofmann TG; Pahernik S; Duensing S; Hohenfellner M; Kopitz J; Schirmacher P; Roth W
    J Pathol; 2015 Dec; 237(4):460-71. PubMed ID: 26178300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and expression of PUMA, MCL-1, and p53 in human renal cell carcinoma and para-carcinoma tissues.
    Xia HB; Cui HW; Su L; Zhang ZH; Yang XY; Ning SQ; Su XL
    Genet Mol Res; 2017 Jul; 16(3):. PubMed ID: 28692117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.